PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis - Test2 - elhamkhani - TriplyDB

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

http://www.wikidata.org/entity/Q26777811

about

Cross Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications Regulatory functional territory of PLK-1 and their substrates beyond mitosis.Dynamic Bcl-xL (S49) and (S62) Phosphorylation/Dephosphorylation during Mitosis Prevents Chromosome Instability and Aneuploidy in Normal Human Diploid Fibroblasts Identification of Polo-like kinases as potential novel drug targets for influenza A virus.Simultaneous use of erythropoietin and LFM-A13 as a new therapeutic approach for colorectal cancer.Erythropoietin Intensifies the Proapoptotic Activity of LFM-A13 in Cells and in a Mouse Model of Colorectal Cancer.

P2860

Q28076060-127D8A52-D11E-43CB-B49E-ECAC2AAC762B Q33914204-3A77AA09-8B4C-4258-A028-F3AF10F2938B Q36072488-52A46F5B-C702-4C6F-AC5A-95281FA05D68 Q40078929-BB7548E9-6C01-42B7-891F-C72C91D680E6 Q47379071-F34CD2DA-EB0D-4164-8369-A39C3FB3CEDF Q54114538-8584D7B6-8D5C-431D-BB32-1FBAEB83DAE8

P2860

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

http://www.wikidata.org/entity/Q26777811

description

2015 nî lūn-bûn

@nan

2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

@ast

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

@en

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

@nl

type

label

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

@ast

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

@en

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

@nl

prefLabel

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

@ast

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

@en

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

@nl

P1433

Q26777811-A05E7069-1855-487C-9598-4A8561D0CF3E

P1476

Q26777811-E199D1B7-8EE0-4984-A34A-3DD8EDFDB8CE

P2093

Q26777811-529CABA6-CB97-4F47-82BE-A879E2E5A4E8

Q26777811-AF490C60-7953-4C6B-9CE1-18B9C2E481E8

P275

Q26777811-3B16ED2D-787B-4303-A0DC-8D7F40945BB1

P2860

Q26777811-08E7DE47-9B88-4C95-9C96-E5F676517C9E

Q26777811-0CD6AC5A-39F1-45A2-B002-BF2E41712ECF

Q26777811-0DC819D9-339A-456B-BCFF-950DC1EA0347

Q26777811-1714D875-40C4-43D5-B89F-2BE527B90BE6

Q26777811-1E11A40E-4FDF-4A12-8315-ED7635AAF32C

Q26777811-1E9CFE50-5899-476C-8FA3-855D3CAB496F

Q26777811-20D39F70-6C85-46CD-A572-8E909DDA6B5B

Q26777811-22BE24DF-E2FC-4B19-A11E-2B31781E4DE6

Q26777811-27A23B1E-CA97-4524-B1D0-427452A40085

Q26777811-30E21497-B725-458E-8FB4-AE3F383763BC

P304

Q26777811-574927A3-2FC2-4800-ADE7-49664F2E29D4

P31

Q26777811-54789A42-22E8-4FCB-99A8-72C99F30F9D2

Q26777811-E126B1D6-B94F-4259-9106-5B8F628D5658

P3181

Q26777811-1C6CD0D9-72D1-4F65-933C-5388E4D4AA73

P356

Q26777811-FD379120-1213-4771-8A90-93C67135DF51

P407

Q26777811-788DD880-1ABD-42AD-830D-9958D2837973

P478

Q26777811-974C49D8-D70D-49BD-9F43-EEE8F391D4EB

P577

Q26777811-459E7D00-A444-4C2C-BC59-CB8C20461013

P5875

Q26777811-9EBEB070-7A72-446B-8A4B-78973AA821C4

P698

Q26777811-9ED50A30-7E2A-4962-9FF4-8EE44D3492D3

P921

Q26777811-13E356A7-B21C-4418-9005-6968C5183D68

Q26777811-43CB9395-B2D1-491D-8370-C7808FBE41F1

Q26777811-48D52818-93F7-40EC-A58C-8BB5B67FD90F

Q26777811-641C8369-8A37-4B23-B5EF-BDB09BC1C777

Q26777811-E578B4D5-C231-4613-B834-156EED3F3EBB

P932

Q26777811-A1B7B692-C6F5-4727-9B3F-27EEF6767A3C

P3181

P356

P1433

BioMed Research International

P1476

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis

@en

P2093

Jaebong Kim

http://www.w3.org/2001/XMLSchema#string

Shiv Kumar

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Plk1-mediated phosphorylation of Topors regulates p53 stability

Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery

The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex

Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells

The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain

Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization

Structure of the catalytic domain of human polo-like kinase 1

Selectivity-determining residues in Plk1

Structures of the wild-type and activated catalytic domains of Brachydanio rerio Polo-like kinase 1 (Plk1): changes in the active-site conformation and interactions with ligands

Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors

P304

705745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

145823

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2015/705745

http://www.w3.org/2001/XMLSchema#string

P407

P478

2015

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

276921837

http://www.w3.org/2001/XMLSchema#string

P698

26557691

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

proto-oncogene proteins

neoplasm proteins

cell cycle proteins

P932

4628734

http://www.w3.org/2001/XMLSchema#string